Properties Linked to the Selection of New Biotherapeutics

Overview

Journal Nutrients

Date 2022 Oct 14

PMID 36235828

Authors

Jordan Chamarande

Lisiane Cunat

Nadine Pavlov

Corentine Alauzet

Catherine Cailliez-Grimal

Affiliations

Soon will be listed here.

Abstract

Dysbiotic microbiota is often associated with health issues including inflammatory bowel disease or ulcerative colitis. In order to counterbalance host disorder caused by an alteration in the gut composition, numerous studies have focused on identifying new biotherapeutic products (NBPs). Among the promising NBPs is , a gut microbiota member part of the core microbiome that recently has received much attention due to the numerous beneficial properties it brings to its host. In this study, the properties linked to the selection of NBPs were screened in 14 unrelated strains, including resistance to gastric conditions, adherence (Caco-2 model), transepithelial resistance (Caco-2 model), and immunomodulation, on nontreated and LPS-stimulated cells (HT-29 and peripheral blood mononuclear cells (PBMCs)). This approach allowed for the identification of five strains that combined almost all the in vitro biotherapeutic properties tested. However, all the strains induced the overproduction of proinflammatory cytokines on PBMCs, which was counteracted by the overproduction of the anti-inflammatory cytokines. Among these five strains, two particularly retained our attention as a potential NBP, by showing strong health-promoting function, the lowest overproduction of proinflammatory cytokines on PBMCs, and no detrimental effect on the host.

Citing Articles

Therapeutic potential of in gastrointestinal and hepatic disease.

Duan J, Li Q, Cheng Y, Zhu W, Liu H, Li F MedComm (2020). 2024; 5(12):e70017.

PMID: 39687780 PMC: 11647740. DOI: 10.1002/mco2.70017.

Evaluation of the Biological Properties of the Bacteriodaceae Family Using the Caco-2 Cell Line.

Podoprigora I, Das M, Zakharzhevskaya N, Kafarskaya L, Efimov B Bull Exp Biol Med. 2024; 178(1):54-57.

PMID: 39572495 DOI: 10.1007/s10517-024-06281-y.

Effect of Probiotic Bacteria on the Gut Microbiome of Mice with Lipopolysaccharide-Induced Inflammation.

Gryaznova M, Burakova I, Smirnova Y, Morozova P, Chirkin E, Gureev A Microorganisms. 2024; 12(7).

PMID: 39065109 PMC: 11278525. DOI: 10.3390/microorganisms12071341.

Rumen and hindgut microbiome regulate average daily gain of preweaning Holstein heifer calves in different ways.

Xu S, Feng X, Zhao W, Bi Y, Diao Q, Tu Y Microbiome. 2024; 12(1):131.

PMID: 39030599 PMC: 11264748. DOI: 10.1186/s40168-024-01844-7.

The potential immunomodulatory role of the gut microbiota in the pathogenesis of asthma: an in vitro study.

Kleniewska P, Kopa-Stojak P, Hoffmann A, Pawliczak R Sci Rep. 2023; 13(1):19721.

PMID: 37957277 PMC: 10643691. DOI: 10.1038/s41598-023-47003-0.

References

Jandhyala S, Talukdar R, Subramanyam C, Vuyyuru H, Sasikala M, Reddy D . Role of the normal gut microbiota. World J Gastroenterol. 2015; 21(29):8787-803. PMC: 4528021. DOI: 10.3748/wjg.v21.i29.8787. View

Polak-Berecka M, Wasko A, Paduch R, Skrzypek T, Sroka-Bartnicka A . The effect of cell surface components on adhesion ability of Lactobacillus rhamnosus. Antonie Van Leeuwenhoek. 2014; 106(4):751-62. PMC: 4158178. DOI: 10.1007/s10482-014-0245-x. View

Playford R, Choudhry N, Kelly P, Marchbank T . Effects of Bovine Colostrum with or without Egg on In Vitro Bacterial-Induced Intestinal Damage with Relevance for SIBO and Infectious Diarrhea. Nutrients. 2021; 13(3). PMC: 8004259. DOI: 10.3390/nu13031024. View

Morais L, Schreiber 4th H, Mazmanian S . The gut microbiota-brain axis in behaviour and brain disorders. Nat Rev Microbiol. 2020; 19(4):241-255. DOI: 10.1038/s41579-020-00460-0. View

Xu J, Mahowald M, Ley R, Lozupone C, Hamady M, Martens E . Evolution of symbiotic bacteria in the distal human intestine. PLoS Biol. 2007; 5(7):e156. PMC: 1892571. DOI: 10.1371/journal.pbio.0050156. View

Wang K, Liao M, Zhou N, Bao L, Ma K, Zheng Z . Parabacteroides distasonis Alleviates Obesity and Metabolic Dysfunctions via Production of Succinate and Secondary Bile Acids. Cell Rep. 2019; 26(1):222-235.e5. DOI: 10.1016/j.celrep.2018.12.028. View

Gibson G, Hutkins R, Sanders M, Prescott S, Reimer R, Salminen S . Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol. 2017; 14(8):491-502. DOI: 10.1038/nrgastro.2017.75. View

Zhang J, An J . Cytokines, inflammation, and pain. Int Anesthesiol Clin. 2007; 45(2):27-37. PMC: 2785020. DOI: 10.1097/AIA.0b013e318034194e. View

Edebol Carlman H, Rode J, Konig J, Repsilber D, Hutchinson A, Thunberg P . Probiotic Mixture Containing , and Affects Brain Responses to an Arithmetic Stress Task in Healthy Subjects: A Randomised Clinical Trial and Proof-of-Concept Study. Nutrients. 2022; 14(7). PMC: 9002567. DOI: 10.3390/nu14071329. View

10.

Hill C, Guarner F, Reid G, Gibson G, Merenstein D, Pot B . Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014; 11(8):506-14. DOI: 10.1038/nrgastro.2014.66. View

11.

Cuffaro B, Assohoun A, Boutillier D, Peucelle V, Desramaut J, Boudebbouze S . Identification of New Potential Biotherapeutics from Human Gut Microbiota-Derived Bacteria. Microorganisms. 2021; 9(3). PMC: 7998412. DOI: 10.3390/microorganisms9030565. View

12.

Koh G, Kane A, Lee K, Xu Q, Wu X, Roper J . Parabacteroides distasonis attenuates toll-like receptor 4 signaling and Akt activation and blocks colon tumor formation in high-fat diet-fed azoxymethane-treated mice. Int J Cancer. 2018; 143(7):1797-1805. DOI: 10.1002/ijc.31559. View

13.

Chamarande J, Cunat L, Alauzet C, Cailliez-Grimal C . In Silico Study of Cell Surface Structures of Involved in Its Maintenance within the Gut Microbiota. Int J Mol Sci. 2022; 23(16). PMC: 9409006. DOI: 10.3390/ijms23169411. View

14.

Cuffaro B, Assohoun A, Boutillier D, Sukenikova L, Desramaut J, Boudebbouze S . In Vitro Characterization of Gut Microbiota-Derived Commensal Strains: Selection of Strains Alleviating TNBS-Induced Colitis in Mice. Cells. 2020; 9(9). PMC: 7565435. DOI: 10.3390/cells9092104. View

15.

Lynch J, Hsiao E . Microbiomes as sources of emergent host phenotypes. Science. 2019; 365(6460):1405-1409. DOI: 10.1126/science.aay0240. View

16.

Papanicolas L, Choo J, Wang Y, Leong L, Costello S, Gordon D . Bacterial viability in faecal transplants: Which bacteria survive?. EBioMedicine. 2019; 41:509-516. PMC: 6444077. DOI: 10.1016/j.ebiom.2019.02.023. View

17.

Kverka M, Zakostelska Z, Klimesova K, Sokol D, Hudcovic T, Hrncir T . Oral administration of Parabacteroides distasonis antigens attenuates experimental murine colitis through modulation of immunity and microbiota composition. Clin Exp Immunol. 2010; 163(2):250-9. PMC: 3043316. DOI: 10.1111/j.1365-2249.2010.04286.x. View

18.

Yang J, Lee Y, Kim Y, Lee S, Ryu S, Fukuda S . Gut commensal Bacteroides acidifaciens prevents obesity and improves insulin sensitivity in mice. Mucosal Immunol. 2016; 10(1):104-116. DOI: 10.1038/mi.2016.42. View

19.

Thursby E, Juge N . Introduction to the human gut microbiota. Biochem J. 2017; 474(11):1823-1836. PMC: 5433529. DOI: 10.1042/BCJ20160510. View

20.

Koh G, Kane A, Wu X, Crott J . Parabacteroides distasonis attenuates tumorigenesis, modulates inflammatory markers and promotes intestinal barrier integrity in azoxymethane-treated A/J mice. Carcinogenesis. 2020; 41(7):909-917. DOI: 10.1093/carcin/bgaa018. View